STOCK TITAN

Eli Lilly and Company (LLY) Stock News, Oct 2-20, 2023

LLY NYSE

Eli Lilly & Co. develops and commercializes medicines across cardiometabolic disease, oncology, immunology, neuroscience and genetic medicine. Company news commonly covers product and pipeline developments for medicines such as Mounjaro, Zepbound, Foundayo, Omvoh, Verzenio, Jaypirca and Taltz, including clinical data, regulatory approvals and treatment-indication updates.

Lilly updates also include operating results, financial guidance, dividends, business development agreements and manufacturing expansion. Recent company communications highlight investment in active pharmaceutical ingredient capacity and genetic medicine production, alongside recurring disclosures about demand for diabetes, obesity, immune-disease and cancer therapies.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.22%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.86%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.38%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.19%
Tags
none
-
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.19%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.43%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
fda rejection

FAQ

What is the current stock price of Eli Lilly (LLY)?

Eli Lilly (LLY) last closed at $1,347.11.

What is the market cap of Eli Lilly (LLY)?

The market cap of Eli Lilly (LLY) is approximately $1.2T.